An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
AbbVie Inc.
Start Date
June 30, 2017
End Date
June 29, 2018
Administered By
Duke Clinical Research Institute
Awarded By
AbbVie Inc.
Start Date
June 30, 2017
End Date
June 29, 2018